Hercules Technology Growth Capital, Inc. Prices Public Offering of Common Stock
September 28 2012 - 8:05AM
Business Wire
Hercules Technology Growth Capital, Inc. (NYSE: HTGC)
("Hercules") announced that it has priced its public offering of
3,100,000 shares of common stock. The offering is subject to
customary closing conditions and is expected to close
on October 3, 2012. The last reported sales price of Hercules'
common stock on September 27, 2012 was $11.42 per
share. Credit Suisse is the sole underwriter of this offering.
Hercules expects to use the net proceeds from this offering to
fund investments in debt and equity securities in accordance with
its investment objective and for other general corporate
purposes.
The securities described above are being offered by Hercules
pursuant to an effective shelf registration statement. The offering
may be made only by means of a prospectus supplement and the
accompanying prospectus, copies of which may be obtained from
Credit Suisse Prospectus Department, One Madison Avenue, New York,
NY 10010; telephone number: 1-800-221-1037; email:
newyork.prospectus@credit-suisse.com.
Investors are advised to carefully consider the investment
objectives, risks, and charges and expenses of Hercules before
investing. The prospectus, which has been filed with
the Securities and Exchange Commission, contains this and
other information about Hercules and should be read carefully
before investing.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy, nor shall there be any sale of,
the shares in any state or other jurisdiction in which such offer,
solicitation or sale would be unlawful prior to the registration or
qualification under the securities laws of any such state or other
jurisdiction.
About Hercules Technology Growth Capital, Inc.:
Hercules Technology Growth Capital, Inc. (NYSE: HTGC), is a New
York Stock Exchange (“NYSE”) traded specialty finance company
focused on providing senior secured loans to entrepreneurial
venture capital and private equity-backed companies in
technology-related markets at all stages of development, including
technology, biotechnology, life science, healthcare services and
clean-tech industries.
Forward-Looking Statements:
The statements contained in this release that are not purely
historical are forward-looking statements. These forward-looking
statements are not guarantees of future performance and are subject
to uncertainties and other factors that could cause actual results
to differ materially from those expressed in the forward-looking
statements including, without limitation, the risks, uncertainties,
including the uncertainties surrounding the current market
turbulence, and other factors we identify from time to time in our
filings with the Securities and Exchange Commission. Although we
believe that the assumptions on which these forward-looking
statements are based are reasonable, any of those assumptions could
prove to be inaccurate and, as a result, the forward-looking
statements based on those assumptions also could be incorrect. You
should not place undue reliance on these forward-looking
statements. The forward-looking statements contained in this
release are made as of the date hereof, and Hercules assumes no
obligation to update the forward-looking statements for subsequent
events.
Hercules Capital (NYSE:HTGC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hercules Capital (NYSE:HTGC)
Historical Stock Chart
From Jul 2023 to Jul 2024